Skip to main content

Table 1 Clinical and biochemical characteristics of the overweight/obese and control subjects ( x ¯ ±s )

From: Effect of the beta-3 adrenergic receptor Trp64Arg and uncoupling protein 1–3826 A > G genotypes on lipid and apolipoprotein levels in overweight/obese and non-obese Chinese subjects

 

Overweight/obese (n = 249)

Controls (n = 169)

P

Age (yrs)

55.04 ± 10.00

53.35 ± 11.78

0.115

Gender (M/F)

149/100

93/76

0.322

TG (mmol/L)

2.31 ± 1.70

1.72 ± 1.56

0.000

TC (mmol/L)

5.43 ± 0.92

5.41 ± 1.11

0.788

HDL-C (mmol/L)

1.17 ± 0.32

1.41 ± 0.41

0.000

LDL-C (mmol/L)

a3.29 ± 0.87

b3.26 ± 1.04

0.821

apoA-I (mg/dL)

124.20 ± 27.96

128.97 ± 23.89

0.077

apoA-II (mg/dL)

28.39 ± 4.58

29.07 ± 6.92

0.227

apoB100 (mg/dL)

88.93 ± 17.06

84.04 ± 20.93

0.427

apoC-II (mg/dL)

6.68 ± 3.32

5.61 ± 3.10

0.001

apoC-III (mg/dL)

17.47 ± 7.03

13.09 ± 6.17

0.000

Apo E (mg/dL)

5.27 ± 1.96

4.87 ± 2.26

0.043

BMI (kg/m2)

25.72 ± 2.25

20.74 ± 1.60

0.000

  1. Subjects with TG > 4.516 mmol/L (400 mg/dL) were excluded when calculating the serum LDL-C levels, a: n = 193, b: n = 145.